Actionability |
Is there a practice guideline or systematic review for the genetic condition? |
Does the practice guideline or systematic review indicate that the result is actionable in one or more of the following ways: a) patient management, b) surveillance or screening, c) family management, or d) circumstances to avoid? |
Is the result actionable in an undiagnosed adult with the genetic condition? |
Penetrance |
Is there at least one known pathogenic variant with at least moderate penetrance (≥40%) or moderate relative risk (≥2) for important health implications in any population? |
Significance/Burden of disease |
Is this condition an important health problem? |
Stage II |
Criteria |
Questions |
Significance/Burden of disease |
What is the nature of the threat to health for an individual carrying a deleterious allele? |
Disease Incidence |
Disease Prevalence |
Clinical Features (Signs/Symptoms) |
Natural History |
Significance/Burden of Condition |
|
Actionability |
How effective are available interventions for preventing the harm? |
Patient Management |
Surveillance |
Family Management |
Circumstances to Avoid |
Penetrance |
What is the chance that this threat will materialize? |
Prevalence |
Penetrance |
Expressivity |
Relative Risk |
Acceptability of Intervention |
How acceptable are available interventions in terms of the burdens or risks placed on the individual? |
Risks |
Would the underlying risk or condition escape detection prior to harm in the setting of recommended care? |
Chance to escape clinical detection in adults |